ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0804
0,00%
Bitcoin
69.377,07
0,10%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Science 37 Holdings Inc (SNCE)

  7. Science 37 Holdings Inc (SNCE) News

SNCE

Science 37 (SNCE)

Science 37 Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SNCE
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202414h00GlobeNewswire Inc.Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and ComplianceNASDAQ:SNCEScience 37 Holdings Inc
09/05/202416h00GlobeNewswire Inc.Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”NASDAQ:SNCEScience 37 Holdings Inc
02/05/202414h00GlobeNewswire Inc.Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical TrialNASDAQ:SNCEScience 37 Holdings Inc
17/04/202414h00GlobeNewswire Inc.Science 37 Provides Fully Consented Patients to Sites to Supplement EnrollmentNASDAQ:SNCEScience 37 Holdings Inc
12/03/202411h45PR Newswire (US)eMed completes tender offer for all outstanding shares of Science 37NASDAQ:SNCEScience 37 Holdings Inc
04/03/202412h18Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SNCEScience 37 Holdings Inc
04/03/202412h01Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:SNCEScience 37 Holdings Inc
20/02/202405h16PR Newswire (US)Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law FirmNASDAQ:SNCEScience 37 Holdings Inc
12/02/202415h03Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SNCEScience 37 Holdings Inc
12/02/202414h16Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:SNCEScience 37 Holdings Inc
12/02/202413h45PR Newswire (US)eMed commences tender offer for Science 37NASDAQ:SNCEScience 37 Holdings Inc
09/02/202413h49Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:SNCEScience 37 Holdings Inc
09/02/202413h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNCEScience 37 Holdings Inc
30/01/202416h11Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:SNCEScience 37 Holdings Inc
29/01/202422h10Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:SNCEScience 37 Holdings Inc
29/01/202413h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNCEScience 37 Holdings Inc
22/12/202322h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNCEScience 37 Holdings Inc
12/12/202314h00GlobeNewswire Inc.Science 37 Receives Top Honors in Everest PEAK Matrix®NASDAQ:SNCEScience 37 Holdings Inc
07/12/202322h59GlobeNewswire Inc.Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNCEScience 37 Holdings Inc
05/12/202313h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNCEScience 37 Holdings Inc
05/12/202313h00GlobeNewswire Inc.Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023NASDAQ:SNCEScience 37 Holdings Inc
29/11/202322h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNCEScience 37 Holdings Inc
10/11/202322h39GlobeNewswire Inc.Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNCEScience 37 Holdings Inc
07/11/202312h39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SNCEScience 37 Holdings Inc
07/11/202312h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNCEScience 37 Holdings Inc
07/11/202312h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNCEScience 37 Holdings Inc
27/10/202322h11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNCEScience 37 Holdings Inc
10/10/202322h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNCEScience 37 Holdings Inc
06/10/202322h41GlobeNewswire Inc.Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNCEScience 37 Holdings Inc
03/10/202322h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNCEScience 37 Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:SNCE

Kürzlich von Ihnen besucht

BIT
P17RQ7
BNP Paribas Issuance
BIT
SX50LC
SG Issuer
BIT
P1DDC5
BNP Paribas Issuance
BIT
F16303
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten